Table 1.

Patient clinical and molecular characteristics (n = 200)

Age
    Mean63.4
    SE12.9
    Range20-100
VariableFGFR3 status inclusion tumor
WT, n (%)Mutant, n (%)
Gender
    Male50 (33)103 (67)
    Female16 (34)31 (66)
Smoking
    No12 (30)28 (70)
    Yes42 (35)78 (65)
Stage
    Ta57 (33)117 (67)
    T19 (35)17 (65)
Grade
    G129 (31)64 (69)
    G237 (35)70 (65)